Maria Concepcion Castells, Ph.D., M.D.
This page shows the publications co-authored by Maria Castells and Matthew Giannetti.
Differential mast cell mediators in systemic mastocytosis and hereditary a-tryptasemia. J Allergy Clin Immunol. 2022 May 09.
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms. J Allergy Clin Immunol Pract. 2021 05; 9(5):2083-2086.
Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis. Ann Allergy Asthma Immunol. 2021 06; 126(6):655-660.
Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome. J Allergy Clin Immunol Pract. 2020 04; 8(4):1196-1201.
One-day ultrarush desensitization for Hymenoptera venom anaphylaxis in patients with and without mast cell disorders with adjuvant omalizumab. J Allergy Clin Immunol Pract. 2020 Apr; 8(4):1431-1435.e3.
Mast cells in lung damage of COVID-19 autopsies: A descriptive study. Allergy. 2022 07; 77(7):2237-2239.
Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy. Ann Allergy Asthma Immunol. 2022 03; 128(3):299-306.e1.
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology. J Allergy Clin Immunol. 2021 04; 147(4):1497-1501.e1.
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116.
Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome. Am J Surg Pathol. 2021 07 01; 45(7):997-1004.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.